Delivery Order SPE2DB22D3016-SPE2DB24FATT6
Award Date 4/26/24
Potential Completion Date 4/29/24
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $12,240.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Contrave ER 8-90 mg tablets, a medication used to treat obesity. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. This IDC...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Contrave ER 8-90 mg tablets. The award, valued at $5,147.96, was made by the Defense Logistics Agency (DLA) and has an ultimate completion date of May 1, 2024. The contract is a firm fixed-price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs,...
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $16,479.13 delivery order contract is for the supply of 4564451660 Contrave ER 8-90 mg Tablets. The contract is a firm fixed-price delivery order with a period of performance through May 1, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., as a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award, valued at $3,585.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Contrave ER 8-90 mg tablets, a pharmaceutical product, to support military healthcare programs. The award has an ultimate completion date of April 26, 2024 and is structured as a firm-fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $8,490.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Contrave ER 8-90 mg tablets in quantities of 120 tablets per bottle. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of pharmaceutical products, including Contrave ER tablets, valued at $1,250.40. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 19, 2023. There was no set-aside designation used for this award. Amerisourcebergen Drug Corp, as a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The $2,786.71 firm fixed-price delivery order contract is for the provision of CONTRAVE ER 8-90 MG TABLET 120S, a medication primarily used to treat obesity. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Firm Fixed Price Delivery Order valued at $7,229.31. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2024 and was awarded on January 29, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,050.22 firm fixed-price contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a medication for treating obesity. The contract has an ultimate completion date of December 14, 2023 and is not designated as a set-aside. Amerisourcebergen, a for-profit organization, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...